Skip to main content
Premium Trial:

Request an Annual Quote

Aushon Biosystems Expands into Chinese Market with LightArray Partnership


By Justin Petrone

Aushon BioSystems has partnered with LightArray Biotech to provide Aushon's suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions in China, the Billerica, Mass.-based firm said this week.

Based in Shanghai, LightArray operates a drug development services laboratory in nearby Wuxi, and will now provide local researchers with protein biomarker testing based on Aushon's protein biomarker platforms.

According to Aushon, its menu includes more than 300 validated arrays, a multiplex biomarker sample testing service, protein biomarker kits, custom array and assay development, and array imaging and analysis systems.

Aushon CEO Pete Honkanen in a statement called the partnership with LightArray "strategic" and said it "enables companies located in China and involved in pre-clinical and clinical research to take advantage" of the firm's products and services.

LightArray CEO Alan Zhang said in a statement that the "adoption of biomarkers as a critical research tool in preclinical and clinical studies is growing rapidly in China," and LightArray's ability to provide regional access to Aushon's products and services will be "vital."

Financial details were not discussed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.